A recently approved immunization drug is helping to limit the severity of a respiratory disease that afflicts young children ...
Medically reviewed by Anju Goel, MD Going viral isn't always a good thing. Cold and flu viruses circulate at their highest ...
Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and ...
Approximately 1 in 20 individuals diagnosed with RSV in outpatient settings were hospitalised within 28 days. Read more.
The NHS has encouraged eligible people to get vaccinated against respiratory syncytial virus (RSV). RSV infections can be ...
Some hospitals in the U.S. are seeing an increase in cases of RSV and so-called "walking pneumonia." Here's what you need to ...
As the holiday season approaches, public health experts are sounding the alarm about low vaccination rates against the ...
Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...
Approximately 1 in 20 adults with outpatient respiratory syncytial virus (RSV) infections were readmitted to the hospital ...
There were 330 COVID-19-like illnesses, 93 RSV-like cases and 62 influenza-like cases recorded statewide for the week ending ...
"Flu tends to impact us a little later in the year, or early into the new year, so that at this point in time for any of the ...
RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...